The goal of this clinical trial is to learn whether a companion software application can improve program engagement in the National Diabetes Prevention Program in adults with prediabetes. The main question\[s\] it aims to answer \[is/are\]: Do participants using the software application (the intervention group) have better engagement with the Diabetes Prevention Program than those who do not use the companion software application (the control group)? Are participants using the software application (the intervention group) more likely to stay in the Diabetes Prevention Program longer than those who do not use the companion software application (the control group)? Participants are those who have signed up for their local Diabetes Prevention Program and agree to be in the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Engagement as measured by number of classes attended by participant
Timeframe: From enrollment to end of the Lifestyle Change Program, up to 12 months.
Retention as measured by percentage of participants that remain enrolled at end of study
Timeframe: From enrollment to end of the Lifestyle Change Program, up to 12 months.
Efficacy as measured by the percentage of participants that achieve the goal of >/= 5% weight loss by end of study
Timeframe: From enrollment to end of the Lifestyle Change Program, up to 12 months.